Question 1

All of the following Westgard rules identify systematic error except:

Accepted Answer

A)  22s for across runs 
B)  10x for across runs 
C)  13s for within run 
D)  22s for within run 
A)  22s for across runs 
B)  10x for across runs 
C)  13s for within run 
D)  22s for within run

Question 2

The mean and control limits are used to construct QC charts known as:

Accepted Answer

A)  Levey-Jennings charts 
B)  Leslie Johnson charts 
C)  Westgard charts 
D)  Linear regression charts 
A)  Levey-Jennings charts 
B)  Leslie Johnson charts 
C)  Westgard charts 
D)  Linear regression charts

Question 3

The Health Insurance Portability and Accountability Act (HIPAA) regulates:

Accepted Answer

A)  Quality Control procedures 
B)  Procedure manual standards 
C)  Patient confidentiality 
D)  Personnel standards 
A)  Quality Control procedures 
B)  Procedure manual standards 
C)  Patient confidentiality 
D)  Personnel standards

Question 4

Specimens are received from the emergency room for CBC, PT, PTT, and Chem panel. Coag results are PT - 7.0 sec (ref range: 9.0-11.2 sec), PTT - 18.9 sec (ref range: 26.0-32.0 sec). What could explain these results?

Accepted Answer

A)  The patient just runs low 
B)  The specimen is lipemic 
C)  The coag tube was drawn after the SST tube 
D)  The coag tube was underfilled 
A)  The patient just runs low 
B)  The specimen is lipemic 
C)  The coag tube was drawn after the SST tube 
D)  The coag tube was underfilled

Question 5

Samples are received from the emergency department for CBC, Chem panel and 'hold' coag tubes. The CBC is assayed and the MCHC is 38.4 g/dl. The "hold" coag tube is centrifuged and the laboratory professional observes that the plasma is opaque and milky in appearance. What are the next steps?

Accepted Answer

A)  Release results commenting that results may be inaccurate 
B)  Perform saline replacement to obtain accurate HGB, calculate new MCH, MCHC, release results with corrected HGB, MCH, MCHC 
C)  Release the results and phone the 'critical value' 
D)  Ask for a redraw 
A)  Release results commenting that results may be inaccurate 
B)  Perform saline replacement to obtain accurate HGB, calculate new MCH, MCHC, release results with corrected HGB, MCH, MCHC 
C)  Release the results and phone the 'critical value' 
D)  Ask for a redraw

Question 6

What are the six elements of a competency assessment program as identified by CLIS '88?

Accepted Answer

a. Direct observation of routine patient

Question 7

List the six IOM healthcare quality aims and state the definition of each.

Accepted Answer

Safe: "avoiding injuries to patients fro

Question 8

An IQCP program includes risk assessment as one of its three components. Which of the following is covered in a risk assessment analysis?

Accepted Answer

A)  Specimen 
B)  Environment 
C)  Testing personnel 
D)  All of the above 
A)  Specimen 
B)  Environment 
C)  Testing personnel 
D)  All of the above

Question 9

'Moving Averages' is a method using what parameter(s) to monitor hematology instrument performance on a continual basis?

Accepted Answer

A)  WBC count 
B)  Platelet count 
C)  RBC indices 
D)  MPV 
A)  WBC count 
B)  Platelet count 
C)  RBC indices 
D)  MPV

Exam 43: Quality Assessment in the Hematology Laboratory

All of the following Westgard rules identify systematic error except:

The mean and control limits are used to construct QC charts known as:

The Health Insurance Portability and Accountability Act (HIPAA) regulates:

Specimens are received from the emergency room for CBC, PT, PTT, and Chem panel. Coag results are PT - 7.0 sec (ref range: 9.0-11.2 sec), PTT - 18.9 sec (ref range: 26.0-32.0 sec). What could explain these results?

Samples are received from the emergency department for CBC, Chem panel and 'hold' coag tubes. The CBC is assayed and the MCHC is 38.4 g/dl. The "hold" coag tube is centrifuged and the laboratory professional observes that the plasma is opaque and milky in appearance. What are the next steps?

What are the six elements of a competency assessment program as identified by CLIS '88?

List the six IOM healthcare quality aims and state the definition of each.

An IQCP program includes risk assessment as one of its three components. Which of the following is covered in a risk assessment analysis?

'Moving Averages' is a method using what parameter(s) to monitor hematology instrument performance on a continual basis?

Introduction

Cellular Homeostasis

Structure and Function of Hematopoietic Organs

Hematopoiesis

The Erythrocyte

Hemoglobin

Granulocytes and Monocytes

Lymphocytes

The Platelet

The Complete Blood Count and Peripheral Blood Smear Evaluation

Introduction to Anemia

Anemias of Disordered Iron Metabolism and Heme Synthesis

Hemoglobinopathies: Qualitative Defects

Thalassemia

Megaloblastic and Nonmegaloblastic Macrocytic Anemias

Hypoproliferative Anemias

Hemolytic Anemia: Membrane Defects

Hemolytic Anemia: Enzyme Deficiencies

Hemolytic Anemia: Immune Anemias

Hemolytic Anemia: Nonimmune Defects

Nonmalignant Disorders of Leukocytes: Granulocytes and Monocytes

Nonmalignant Lymphocyte Disorders

Introduction to Hematopoietic Neoplasms

Myeloproliferative Neoplasms

Myelodysplastic Syndromes

Acute Myeloid Leukemias

Precursor Lymphoid Neoplasms

Mature Lymphoid Neoplasms

Hematopoietic Stem Cell Transplantation

Morphologic Analysis of Body Fluids in the Hematology

Primary Hemostasis

Secondary Hemostasis and Fibrinolysis

Disorders of Primary Hemostasis

Disorders of Secondary Hemostasis

Thrombophilia

Hemostasis: Laboratory Testing and Instrumentation

Hematology Procedures

Bone Marrow Examination

Automation in Hematology

Flow Cytometry

Chromosome Analysis of Hematopoietic and Lymphoid Disorders

Molecular Analysis of Hematologic Diseases

Filters